Cargando…
Targeting MTHFD2 in acute myeloid leukemia
Drugs targeting metabolism have formed the backbone of therapy for some cancers. We sought to identify new such targets in acute myeloid leukemia (AML). The one-carbon folate pathway, specifically methylenetetrahydrofolate dehydrogenase-cyclohydrolase 2 (MTHFD2), emerged as a top candidate in our an...
Autores principales: | Pikman, Yana, Puissant, Alexandre, Alexe, Gabriela, Furman, Andrew, Chen, Liying M., Frumm, Stacey M., Ross, Linda, Fenouille, Nina, Bassil, Christopher F., Lewis, Caroline A., Ramos, Azucena, Gould, Joshua, Stone, Richard M., DeAngelo, Daniel J., Galinsky, Ilene, Clish, Clary B., Kung, Andrew L., Hemann, Michael T., Vander Heiden, Matthew G., Banerji, Versha, Stegmaier, Kimberly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925018/ https://www.ncbi.nlm.nih.gov/pubmed/27325891 http://dx.doi.org/10.1084/jem.20151574 |
Ejemplares similares
-
SYK Regulates mTOR Signaling in AML
por: Carnevale, Julia, et al.
Publicado: (2013) -
P410: COMBINING MENIN AND MEK INHIBITION TO TREAT CHILDREN WITH POOR PROGNOSTIC KMT2A-R RAS-MUTANT ACUTE LEUKEMIA
por: Scheidegger, Nastassja, et al.
Publicado: (2023) -
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
por: Pikman, Yana, et al.
Publicado: (2021) -
A new posttranslational regulation of REDD1/DDIT4 through cleavage by caspase 3 modifies its cellular function
por: Puissant, A, et al.
Publicado: (2014) -
Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia
por: Boros, Katalin, et al.
Publicado: (2015)